Caris Life Sciences, Inc. Common Stock (CAI) Stock
NASDAQ · CAI
29.98
Fundamentals
Market cap
$8.47B
Price / Earnings ratio
83.1x
Price / Sales ratio
8.8x
Price / Book ratio
14.8x
Return on assets
-0.4%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About Caris Life Sciences, Inc. Common Stock
No description available.
SectorHealthcare
IndustryBiotechnology
Employees1,846
CEODr. David Dean Halbert M.D.
IPO DateJun 18, 2025
HeadquartersIrving, TX
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. David Dean Halbert M.D. | Chairman, CEO & Founder | 1956 |
| Mr. Brian J. Brille J.D. | Executive Vice Chairman & Executive VP | 1961 |
| Dr. David Spetzler M.B.A., M.S., Ph.D. | President | 1977 |
| Mr. J. Russel Denton | Senior VP, General Counsel & Secretary | 1984 |
| Mr. Luke Power | Senior VP, CFO & Chief Accounting Officer | 1982 |
| Mr. Jon Mark Harmon | Senior VP & Chief Operations Officer | — |
| Dr. Valeriy Domenyuk | Senior VP & CTO | — |
| Dr. Milan Radovich Ph.D. | Senior VP & Chief Scientific Officer | — |
| Mr. Jeremy O'Brien | Senior Vice President of Human Resources & Chief Compliance Officer | — |
| Mr. Narendra Chokshi | Senior Vice President of Corporate Development | — |
Fundamentals
Valuation
Market cap$8.47B
Price-to-sales ratio8.83
Price-to-book value14.77
Price-earnings ratio83.10
Return on Equity-78.00%
Return on Sales0.10%
Return on AssetsN/A
PEG ratioN/A
Earnings Per Share
Earnings Per Share$1.70
Income Statement
Average volume5,324,258
EBITDA$116.82M
1 year high (52w)$34.54
1 year low (52w)$14.19
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



